AVNS
Avanos Medical, Inc.
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Best Orthopedic Devices Stocks 2026 →
Avanos Medical (AVNS) Stock: Buy, Sell, or Hold?
$24.99
+0.01 (+0.04%)
â˛
5d:
+0.08%
30d:
+0.16%
90d:
+1.13%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (72%)
Quality Score
49/100
Position
FAIR
Forward P/E & Valuation
20.0x
STRETCHED
vs 15.7x historical avg
Wall Street Target
$14.00
-44.0% vs target
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$24.93 / $25.00
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: AVNS is fairly priced but lacks strong directional signals. At 8.4% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Get Alerted When AVNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$38.22
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$23.73
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AVNS is currently trading at $24.99, which is considered fair based on recent price action. From a valuation perspective, the stock is trading at a premium (Forward PE: 20.0) compared to its historical average (15.7). At these levels, the market is pricing in 8.4% annual earnings growth.
Technical Outlook: Technically, AVNS is in a strong uptrend. The price is currently testing key support at $24.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AVNS scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $14.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AVNS is in a strong uptrend. The price is currently testing key support at $24.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AVNS scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $14.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
49/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
72.4%
Trading Range & Key Levels
Support Level
$24.93
Resistance Level
$25.00
Current Trend
Strong Uptrend
Technical data as of
Jul 24, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BEARISH: Trading 44.0% above Wall St target ($14.00)
- BULLISH: Expecting earnings turnaround to 8.4% growth with 8.8% revenue growth
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
19.99
Wall Street Target
$14.00
(-44.0%)
Revenue Growth (YoY)
8.8%
Earnings Growth (YoY)
-21.7%
Profit Margin
-10.4%
Valuation Premium vs History
+8.4% premium
PE vs Historical
20.0 vs 15.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.4%
(market-implied from PE analysis)
1-Year Target
$27.09
(+8%)
2-Year Target
$29.36
(+18%)
3-Year Target
$31.83
(+27%)
3-Yr Target (if PE normalizes)
(PE: 20â16)
PE COMPRESSION
$25.00
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.8, Growth: 25.0%)
$50.81
(+103%)
Base:
(SPY PE: 20.0, Growth: 25.0%)
$48.81
(+95%)
Bear:
(PE: 15.7, Growth: 25.0%)
$38.33
(+53%)
Share AVNS Analysis
Share this live AVNS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (AVNS)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
May 28, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits is currently buzzing with bullish sentiment towards $AVNS, with one user expressing a 'Kaboomy' outlook. No recent news articles were found on Yahoo Finance.
Key Retail Themes:
Bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:53 AM ET
Data refreshes hourly during market hours. Next update: 2:53 AM
Data refreshes hourly during market hours. Next update: 2:53 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 52 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 39 SELL |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 45 HOLD |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
16 analysts |
$166 | 46 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive AVNS Research Pages
